(APD) Air Products Chemicals - Ratings and Ratios
Atmospheric Gases, Process Gases, Specialty Gases, Industrial Equipment
Dividends
| Dividend Yield | 3.43% |
| Yield on Cost 5y | 3.75% |
| Yield CAGR 5y | -0.23% |
| Payout Consistency | 47.7% |
| Payout Ratio | 59.4% |
| Risk via 10d forecast | |
|---|---|
| Volatility | 24.5% |
| Value at Risk 5%th | 36.7% |
| Relative Tail Risk | -8.66% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.92 |
| Alpha | -32.82 |
| CAGR/Max DD | -0.12 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.309 |
| Beta | 0.794 |
| Beta Downside | 0.832 |
| Drawdowns 3y | |
|---|---|
| Max DD | 31.77% |
| Mean DD | 13.19% |
| Median DD | 12.87% |
Description: APD Air Products Chemicals December 03, 2025
Air Products and Chemicals (APD) supplies a broad portfolio of atmospheric, process, and specialty gases-including oxygen, nitrogen, hydrogen, helium, and carbon-based gases-plus related equipment for air separation, hydrocarbon recovery, and liquefied gas handling across North America, Europe, Asia, the Middle East, and India.
Key economic drivers for APD are the global push toward decarbonization, which fuels demand for clean-hydrogen production and carbon-capture technologies, and the ongoing growth in LNG infrastructure that underpins natural-gas-related gas sales. In FY 2024 the company reported revenue of roughly $16.5 billion and an operating margin near 13%, reflecting strong pricing power in a sector with limited competition.
Sector-specific trends such as rising industrial output in emerging markets and the expansion of semiconductor and medical-device manufacturing continue to lift demand for high-purity specialty gases, while APD’s capital-intensive equipment business benefits from long-term service contracts and recurring maintenance revenue.
For a deeper dive into APD’s valuation metrics and scenario analysis, you might explore the detailed breakdown on ValueRay.
Piotroski VR‑10 (Strict, 0-10) 2.5
| Net Income (-394.5m TTM) > 0 and > 6% of Revenue (6% = 722.2m TTM) |
| FCFTA -0.09 (>2.0%) and ΔFCFTA -1.21pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 13.35% (prev 18.04%; Δ -4.69pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.08 (>3.0%) and CFO 3.26b > Net Income -394.5m (YES >=105%, WARN >=100%) |
| Net Debt (16.46b) to EBITDA (1.34b) ratio: 12.31 <= 3.0 (WARN <= 3.5) |
| Current Ratio 1.38 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (222.9m) change vs 12m ago 0.04% (target <= -2.0% for YES) |
| Gross Margin 31.41% (prev 32.50%; Δ -1.09pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 29.86% (prev 30.58%; Δ -0.72pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio -1.06 (EBITDA TTM 1.34b / Interest Expense TTM 214.0m) >= 6 (WARN >= 3) |
Altman Z'' 3.06
| (A) 0.04 = (Total Current Assets 5.83b - Total Current Liabilities 4.22b) / Total Assets 41.06b |
| (B) 0.43 = Retained Earnings (Balance) 17.56b / Total Assets 41.06b |
| (C) -0.01 = EBIT TTM -226.7m / Avg Total Assets 40.32b |
| (D) 1.38 = Book Value of Equity 32.62b / Total Liabilities 23.71b |
| Total Rating: 3.06 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 29.21
| 1. Piotroski 2.50pt |
| 2. FCF Yield -5.11% |
| 3. FCF Margin -31.28% |
| 4. Debt/Equity 1.22 |
| 5. Debt/Ebitda 12.31 |
| 6. ROIC - WACC (= -6.84)% |
| 7. RoE -2.55% |
| 8. Rev. Trend -27.44% |
| 9. EPS Trend 69.92% |
What is the price of APD shares?
Over the past week, the price has changed by +0.54%, over one month by +8.77%, over three months by -10.03% and over the past year by -19.25%.
Is APD a buy, sell or hold?
- Strong Buy: 10
- Buy: 5
- Hold: 8
- Sell: 1
- Strong Sell: 0
What are the forecasts/targets for the APD price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 310.8 | 19.4% |
| Analysts Target Price | 310.8 | 19.4% |
| ValueRay Target Price | 242.2 | -7% |
APD Fundamental Data Overview November 25, 2025
P/E Forward = 19.802
P/S = 4.7592
P/B = 3.8129
P/EG = 6.6869
Beta = 0.871
Revenue TTM = 12.04b USD
EBIT TTM = -226.7m USD
EBITDA TTM = 1.34b USD
Long Term Debt = 16.95b USD (from longTermDebt, last quarter)
Short Term Debt = 751.0m USD (from shortTermDebt, last quarter)
Debt = 18.31b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 16.46b USD (from netDebt column, last quarter)
Enterprise Value = 73.75b USD (57.29b + Debt 18.31b - CCE 1.86b)
Interest Coverage Ratio = -1.06 (Ebit TTM -226.7m / Interest Expense TTM 214.0m)
FCF Yield = -5.11% (FCF TTM -3.77b / Enterprise Value 73.75b)
FCF Margin = -31.28% (FCF TTM -3.77b / Revenue TTM 12.04b)
Net Margin = -3.28% (Net Income TTM -394.5m / Revenue TTM 12.04b)
Gross Margin = 31.41% ((Revenue TTM 12.04b - Cost of Revenue TTM 8.26b) / Revenue TTM)
Gross Margin QoQ = 32.25% (prev 32.51%)
Tobins Q-Ratio = 1.80 (Enterprise Value 73.75b / Total Assets 41.06b)
Interest Expense / Debt = 0.37% (Interest Expense 67.8m / Debt 18.31b)
Taxrate = 91.67% (111.2m / 121.3m)
NOPAT = -18.9m (EBIT -226.7m * (1 - 91.67%)) [loss with tax shield]
Current Ratio = 1.38 (Total Current Assets 5.83b / Total Current Liabilities 4.22b)
Debt / Equity = 1.22 (Debt 18.31b / totalStockholderEquity, last quarter 15.02b)
Debt / EBITDA = 12.31 (Net Debt 16.46b / EBITDA 1.34b)
Debt / FCF = -4.37 (negative FCF - burning cash) (Net Debt 16.46b / FCF TTM -3.77b)
Total Stockholder Equity = 15.49b (last 4 quarters mean from totalStockholderEquity)
RoA = -0.96% (Net Income -394.5m / Total Assets 41.06b)
RoE = -2.55% (Net Income TTM -394.5m / Total Stockholder Equity 15.49b)
RoCE = -0.70% (EBIT -226.7m / Capital Employed (Equity 15.49b + L.T.Debt 16.95b))
RoIC = -0.06% (negative operating profit) (NOPAT -18.9m / Invested Capital 31.92b)
WACC = 6.78% (E(57.29b)/V(75.60b) * Re(8.94%) + D(18.31b)/V(75.60b) * Rd(0.37%) * (1-Tc(0.92)))
Discount Rate = 8.94% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 81.65 | Cagr: 0.02%
Fair Price DCF = unknown (Cash Flow -3.77b)
EPS Correlation: 69.92 | EPS CAGR: 8.23% | SUE: 0.08 | # QB: 0
Revenue Correlation: -27.44 | Revenue CAGR: 1.51% | SUE: 0.27 | # QB: 0
EPS next Quarter (2026-03-31): EPS=3.03 | Chg30d=+0.003 | Revisions Net=+2 | Analysts=17
EPS current Year (2026-09-30): EPS=12.91 | Chg30d=+0.002 | Revisions Net=+7 | Growth EPS=+7.3% | Growth Revenue=+3.8%
EPS next Year (2027-09-30): EPS=13.89 | Chg30d=-0.172 | Revisions Net=-2 | Growth EPS=+7.6% | Growth Revenue=+5.4%
Additional Sources for APD Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle